At sites of bone fracture, naturally-occurring electric fi elds (EFs) exist during healing and may guide cell migration. In this study, we investigated whether EFs could direct the migration of bone marrow mesenchymal stem cells (BM-MSCs), which are known to be key players in bone formation. Human BM-MSCs were cultured in direct current EFs of 10 to 600 mV/mm. Using time-lapse microscopy, we demonstrated that an EF directed migration of BM-MSCs mainly to the anode. Directional migration occurred at a low threshold and with a physiological EF of ~25 mV/mm. Increasing the EF enhanced the MSC migratory response. The migration speed peaked at 300 mV/mm, at a rate of 42 ±1 μm/h, around double the control (no EF) migration rate. MSCs showed sustained response to prolonged EF application in vitro up to at least 8 h. The electrotaxis of MSCs with either early (P3-P5) or late (P7-P10) passage was also investigated. Migration was passage-dependent with higher passage number showing reduced directed migration, within the range of passages examined. An EF of 200 mV/mm for 2 h did not affect cell senescence, phenotype, or osteogenic potential of MSCs, regardless of passage number within the range tested (P3-P10). Our fi ndings indicate that EFs are a powerful cue in directing migration of human MSCs in vitro. An applied EF may be useful to control or enhance migration of MSCs during bone healing.
Introduction
Bone regeneration/repair occurs not only by the surrounding mature bone cells (e.g. osteoblasts and osteoclasts) but also by migration of bone marrow-derived mesenchymal stem cells (BM-MSCs) to sites of injury and subsequent differentiation into mature osteoblasts, thus contributing to bone regeneration (e.g. osteogenesis) (Bianco and Robey, 2001; Granero-Molto et al., 2009; Mauney et al., 2010; Reichert et al., 2010; Reichert et al., 2011) . Directional migration of BM-MSCs therefore is an essential process in bone repair. Thus, understanding how directional migration of BM-MSCs is controlled is of patho-physiological and clinical importance.
Wounds generate naturally-occurring endogenous electric fi elds (EFs) that play a signifi cant role in guiding cell migration by a process known as electrotaxis Nuccitelli, 2003; Reid et al., 2005; Zhao et al., 1999; Zhao et al., 2006) . Similar endogenous EFs have been identifi ed and measured in various tissues and organs in vitro and in vivo including bone, and may be important for development, regeneration and wound healing (Barker et al., 1982; Bassett and Becker, 1962; Borgens, 1984; Foulds and Barker, 1983; Hammerton et al., 1991; Levin and Verkman, 2005; Levin et al., 2006; Reid et al., 2005; Welsh, 1987; Zhao et al., 2006) . Importantly, externally applied electrical stimulation, either comparable to or signifi cantly higher than the endogenous EFs, has been shown to be an effective approach to accelerate bone healing and remodelling (Aaron et al., 2004; Bassett and Becker, 1962; Bassett et al., 1964; Brighton et al., 1981; Brighton and Pollack, 1985; Dejardin et al., 2001; Fitzsimmons et al., 1986; Hammerick et al., 2010; Hodges et al., 2003; Isaacson and Bloebaum, 2010; Lavine and Grodzinsky, 1987; . Thus, one effect of externally applied EFs may be to act as a cue to direct migration of BM-MSCs in bone regeneration and repair.
Many cell types including bone cells respond to applied EFs in vitro at fi eld strengths comparable to the endogenous wound EFs in vivo. In many cases, cells such as rat osteoblasts, bovine chondrocytes, bovine aortic vascular endothelial cells, and mouse endothelial progenitor cells migrate towards the cathode (Chao et al., 2000; Ferrier et al., 1986; Li and Kolega, 2002; Ozkucur et al., 2009; Zhao et al., 2011) . However, some cells including rabbit osteoclasts, human osteosarcoma cells, rabbit corneal endothelial cells, and human umbilical vein endothelial cells migrate in the opposite direction, towards the anode (Chang et al., 1996; Ferrier et al., 1986; Ozkucur Z Zhao et al. Electrotaxis of bone marrow mesenchymal stem cells Zhao et al., 2004) . These diverse responses indicate that the effects of direct current (DC) EFs on cells are cell-type and species specifi c. Thus, cell electrotaxis needs to be established experimentally on a case-by-case basis.
MSCs have been identified in many adult tissues including bone marrow (Pittenger et al., 1999) , adipose (Zuk et al., 2002) , periosteum (De Bari et al., 2001a; De Bari et al., 2006) , and synovial membrane (De Bari et al., 2001b; De Bari et al., 2003; De Bari et al., 2004) . They are plastic-adherent fi broblast-like cells, express CD105, CD73 and CD90, lack expression of CD45 (Dominici et al., 2006) and have single-cell inherent ability to differentiate into mesenchymal lineages including bone (Pittenger et al., 1999) . Due to their ease of access and culture as well as their known osteogenic potency, MSCs are obvious candidates for bone regeneration/repair applications. So far, the migration of human bone marrow MSCs has not been characterised in detail, in particular in the presence of EFs.
Here we show that BM-MSCs respond to a weak applied EF with strong migration towards the anode. We also show that physiological levels of EF stimulation do not alter cell senescence, osteogenic potential and phenotype of MSCs, making an EF an attractive guidance cue for MSCs.
Methods

Chemicals, reagents and solutions
Dulbecco's modifi ed Eagle's medium (DMEM), fetal bovine serum (FBS), and phosphate-buffered saline (PBS) without Ca 2+ or Mg 2+ were from Lonza (Slough, UK). HEPES buffer solution (HEPES), antibiotic antimycotic (AA) solution, and 0.25 % trypsin-EDTA were from Invitrogen (Paisley, UK). Dexamethasone, β-glycerophosphate disodium salt hydrate, L-ascorbic acid, Alizarin Red S, propidium iodide and trypan blue were from Sigma (Gillingham, UK). 100 mm non-treated tissue culture dishes were from Corning (Poole, UK).
Cell culture
Adult human bone marrow-derived MSCs from 3 donors were used. MSCs from donor 1 (23 years old) were derived, after informed consent and with appropriate ethical approval, by CDB in the Laboratory for Skeletal Development and Joint Disorders, Catholic University of Leuven, Belgium. MSCs from donor 2 (48 years old) and donor 3 (60 years old) were obtained commercially from PromoCell (Heidelberg, Germany). Cells were plated at a density of 3,000 cells/cm 2 in a T75 fl ask and serially passaged at sub-confl uence every 5-7 days at the same initial density. Cells were maintained in growth medium consisting of DMEM supplemented with 10 % (v/v) FBS and 1 % (v/v) AA, at 37 C in a 5 % CO 2 incubator. Cells were cryopreserved in multiple vials in liquid nitrogen at both passage 1 and passage 2, then were thawed as needed and culture-expanded for the experiments described below. All results were from cells between passage 3 and passage 10, as indicated.
Cell migration and electrotaxis assay
Cell motility was assayed using an electrotaxis apparatus (Song et al., 2007; Zhao et al., 2006) . Cells (5,000 cells/ cm 2 ) were seeded and allowed to grow for at least 24 h in culture chambers in DMEM [supplemented with 10 % (v/v) FBS and 1 % (v/v) AA] at 37 C in a 5 % CO 2 incubator. Immediately before a test, medium was replaced with DMEM [supplemented with 10 % (v/v) FBS and 1 % (v/v) AA] containing 25 mM HEPES. For electric fi eld application, a DC EF was applied through agar-salt bridges connecting silver/silver chloride electrodes in beakers of Steinberg's solution, to pools of culture medium on either side of the chamber. A roof of No. 1 (0.13 mm) cover glass was applied and sealed with silicone grease (Corning DC4). The fi nal dimensions of the chamber, through which current was passed, were 40 mm x 10 mm x 0.2 mm. Cells were exposed to an EF for 2-10 h as indicated at 37 °C in a temperature-controlled chamber on an inverted microscope stage. Serial time-lapse images were recorded using a Nikon ECLIPSE TE2000-U microscope and Simple PCI imaging system (Hamamatsu Corporation, PA, USA).
Quantifi cation of cell migration
Directional cell migration was quantifi ed as directedness and migration rate by tracing the position of cell nuclei relative to their original position at t = 0, at a frame interval of 15 min using Image J software (NIH). The directedness of migration was defi ned as cosine  (Zhao et al., 2006) , where  is the angle between the EF vector and a straight line connecting the start and end position of a cell. A cell moving directly towards the anode would have a directedness of 1; a cell moving directly along the fi eld lines towards the cathode would have a directedness of -1; a mean value close to 0 represents random cell movement. The cosine  will provide a number between -1 and +1 and the average of all the separate cell events yields an average directedness index. The average directedness of a population of cells gives an objective quantifi cation of how cells have moved in relation to the EF vector.
The trajectory speed (Tt/T) is the total length of the trajectory (Tt) that a cell has migrated divided by the time (T). The displacement speed (Td/T) is the straight-line distance between the start and end positions of a cell (Td) divided by time (T). Displacement of the cell along the X axis (Dx/T) is the projection of the cell trajectory on the X axis (Dx) divided by the time (T), which represents the migration of cells along the EF vector.
Cell viability
Cell viability was assessed using the trypan blue assay. Senescence-associated β-galactosidase staining The senescence-associated β-galactosidase (SA-β-gal) assay was performed using a β-gal staining kit (Cell Signalling, Hitching, UK) as described (De Bari et al., 2001b) . Cells were plated in chamber slides and allowed to attach in growth medium. Cells were washed in PBS, fi xed Z Zhao et al.
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Images were acquired from a microscope, and β-galpositive senescent cells were counted and shown as a proportion of 1,000 cells assessed in three independent investigations.
Flow cytometry
Culture-expanded MSC populations were used for fl ow cytometry at 10 5 cells/test. Test antibodies were as follows: PerCP-Cy5.5-conjugated CD45 and FITC-conjugated CD90 were from BD Pharmingen (Oxford, UK); phycoerythrin (PE)-conjugated CD105 and allophycocyanin (APC)-conjugated CD73 were from eBiosciences (Hatfield, UK). Isotype-specifi c negative control antibodies were purchased from BD Pharmingen and eBiosciences. Data were acquired using BD FACScalibur, BD LSR II and CellQuest software. Dead cells were gated out based on propidium iodide exclusion. All fl ow cytometry data were analysed with FlowJo 7.6 (Tree Star Inc, Ashland, OR, USA).
Osteogenesis assay
The in vitro osteogenesis assay was performed as previously described (Karystinou et al., 2009) . Briefl y, immediately after EF exposure of 200 mV/mm for 2 h, EF-treated and untreated control MSCs were trypsinised off the EF chamber and plated in 24-well plates at a density of 6,000 cells/well (~2 cm 2 ) for osteogenic differentiation. Each donor was plated in quadruplicate. For the fi rst 24 h post-seeding, cells were cultured in growth medium. Then cells were refreshed twice a week with either osteogenic medium, consisting of growth medium supplemented with 10 mM β-glycerophosphate, 0.05 mM ascorbic acid and 100 nM dexamethasone, or growth medium alone for control. After 4 weeks, cells were rinsed twice with PBS, fi xed with 100 % methanol for 1 h at -20 °C and covered with 2 % Alizarin Red S solution (pH 4.2) for 5 min. Cultures were then washed thoroughly with distilled water. Photographs were acquired using a scanner. After that, staining was dissolved by 0.5 N HCl -5 % sodium dodecyl sulphate (SDS). The absorbance of the solubilised stain was measured in a spectrophotometer at 415 nm.
Statistical analysis
Data are reported as mean ± standard error of the mean (SEM), with n denoting the number of tests except in the migration assay where n denotes the number of cells. Means were compared using one-way analysis of variance (ANOVA) in group comparison. Two-tailed Student's t-test for unpaired data was applied as appropriate. A value of p < 0.05 was considered statistically signifi cant.
Results
Migration of MSCs in response to DC EFs in vitro
In the absence of a DC EF, cells migrated randomly with 48 % of cells moving to one side of the dish and 52 % towards the other side ( Fig. 1C, F ; Fig. 2A ). In the presence of an EF, cells migrated towards the anode (+ve pole; Fig. 1A , A', B, B'. D, E and F). Anodal directed cell migration was voltage-dependent and was evident already at an EF as low as 25 mV/mm, since directedness of migration at 25 mV/ mm was 0.18 ±0.04 (n = 243 cells) compared with 0.00 ±0.06 (n = 161 cells) for the no EF control cells (p < 0.05, one-way ANOVA; Fig. 1F ). The increased directedness of cells peaked in an EF of 300 mV/mm, with a directedness of 0.61 ±0.04 (n = 142 cells; Fig. 1F ). Within total MSC populations, the percentage of cells that migrated towards the anode was 65 % at 25 mV/mm and increased with higher fi eld strengths to plateau at around 85 % at EFs ranging between 200 and 600 mV/mm ( Fig. 2A) . In an EF of 200 mV/mm over 2 h, 15 % of cells migrated towards the cathode but none of these migrated more than 60 μm; by contrast, 85 % of cells migrated towards the anode with 38 % of all cells migrating more than 60 μm (Fig. 2B ). When the EF polarity was reversed after 3 h, cells migrated towards the new anode (compare . Cell migration speed along the x axis (Dx/T) signifi cantly increased when exposed to EFs of ≥100 mV/ mm. Trajectory migration speed (Tt/T) and displacement migration speed (Td/T) also signifi cantly increased in EFs of ≥200 mV/mm (p < 0.05 compared with no EF control; Fig. 1G ). The increased migration speed of cells peaked in an EF of 300 mV/mm, with a Tt/T of 42 ±1 μm/h, close to double the no EF control migration rate (n = 142 cells; Fig. 1G ). This indicates that EFs, at physiological voltages, strongly direct MSC migration and enhance cell migration speed.
Migration of MSCs in a physiological EF is passagedependent
MSCs were passaged serially from passage 3 (P3) to passage 10 (P10). As expected, cells (donor 1) in either early passage (i.e. P3-5) or late passage (i.e. P7 and P10) migrated randomly in the absence of a DC EF (data not shown). This observation was confi rmed with cells of donor 2 and donor 3. In an EF of 200 mV/mm for 2h, cells at early passage (i.e. P3-5) or late passage (i.e. P7 and P10) clearly migrated towards the anode (Fig. 3A) . Cells (donor 1 and 3) showed a significantly higher degree of directedness at low passage (P3), as compared to cells at later passages (p < 0.05, one-way ANOVA; Fig. 3A ). Cells (donor 2) showed a similar trend for a decreased directedness at P7 and P10, although this was not statistically signifi cant (Fig. 3A) .
In the absence of a DC EF, P3 cells (donor 2) showed the fastest trajectory migration speed (Tt/T; 32 ±1 μm/h, n = 325 cells; p < 0.05, one-way ANOVA) and displacement migration speed (Td/T; 18 ±1 μm/h, n = 325 cells; p < 0.05, one-way ANOVA; Fig. 3C ), as compared to later passage cells. Similar results were obtained with cells of donor 3 (Fig. 3D) . In an EF of 200 mV/mm, cells of all three donors showed a faster migration at each passage than cells cultured in the absence of an EF (p < 0.05, Fig.  3B-D) , consistent with the results shown in Fig. 1 . Cells of passage 3 (donor 1) showed the fastest migration speed for both trajectory migration speed (Tt/T; 40 ±3 μm/h, n = 338 cells; p < 0.05, one-way ANOVA) and displacement Z Zhao et al. Electrotaxis of bone marrow mesenchymal stem cells Fig. 3C and D) . These results show that MSCs respond to a DC EF of 200 mV/mm with a directional migration that is passage dependent. These results also show that cell migration speed in the absence of directional cues is passage dependent. This further confi rms that EFs are a physiological cue which directs MSC migration and increases cell migration speed.
Viability and cell senescence of MSCs after EF
To verify that MSCs were not damaged by applied DC EFs, the viability of cells (three different donors) following a 2 h culture exposed to an EF of 200 mV/mm was compared with that of cells cultured for 2 h under similar conditions but without an EF. The percentage of viable cells as assessed by trypan blue dye exclusion (~90-95 %; n = 3; Fig. 4A ) and cell yield data (not shown) were similar between the groups (p > 0.05, one-way ANOVA).
The viability of cells (donor 1; passage 7) following a 2 h culture of 600 mV/mm was also checked. The percentage of viable cells (~90-95 %; n = 3; Fig. 4B ) and cell yield ( Cell senescence was checked by staining MSCs (donor 1) for SA-β-gal. In conditions with no applied EF, 4 % of cells were β-gal positive at passage 3, while 7 % of cells were β-gal positive at passage 7. Similar results were obtained after application of an EF of 200 mV/mm. Both showed statistical difference (Fig. 5) . However, no signifi cant differences were observed between cells with or without EF application at early passage (e.g. passage 3) or late passage (e.g. passage 7) (Fig. 5I) . This indicates that an EF of 200 mV/mm does not affect cell senescence of MSCs, and suggests that cells becoming senescent could be a reason why MSCs lose migration potency at late passage, regardless of EF application.
Migration of MSCs in response to prolonged EF stimulation
To investigate whether the viability and migratory response of MSCs observed in an applied EF for 2 h (Figs 1 and 4 ) are maintained over a prolonged period of EF stimulation, MSCs (donor 2; passage 6) were cultured in an EF of 200 mV/mm for 10 h (Fig. 6) . Without an EF, as expected, cells migrated randomly (data not shown). MSCs migrated towards the anode in response to an EF of 200 mV/mm in 10 h culture with directedness of 0.52 ±0.06 (n = 100 cells) at the fi rst 2 h. The directedness of response lasted 8 h. After that, the response dropped off to nearly half of that observed over the initial 2 h period with directedness of 0.29 ±0.06 (n = 100 cells) at the fi fth 2 h period (Fig.  6A ). In the absence of an EF, cells migrated at a speed of 30 ±2 μm/h (Td/T; n = 100 cells) and 17 ±2 μm/h (Tt/T; n = 100 cells) at the fi rst 2 h, and this lasted 8 h. After this time, the migration speed dropped to 25 ±1 μm/h (Td/T; n = 100 cells) and 13 ±1 μm/h (Tt/T; n = 100 cells) at the fi fth 2 h. In an EF of 200 mV/mm, cells migrated at a speed of 35 ±2 μm/h (Td/T; n = 100 cells) and 22 ±1 μm/h (Tt/T; n = 100 cells) at the fi rst 2 h. The migration speed peaked at the second 2 h slot with a speed of 37 ±2 μm/h (Td/T; n = 100 cells) and 24 ±1 μm/h (Tt/T; n = 100 cells). This migration speed was signifi cantly increased by EFs at the second 2 h slot compared to that of cells in no EFs in the same time point. After 6 h, the migration speed dropped off to 25 ±1 μm/h (Td/T; n = 100 cells) and 16 ±1 μm/h (Tt/T; n = 100 cells) at the fourth 2 h (Fig. 6B ). This suggests that MSCs are able to respond to prolonged application of 200 mV/mm in culture. 
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Phenotype and osteogenic differentiation of MSCs after EF application
To evaluate the phenotype of MSCs after exposure to an EF, fl ow cytometry analysis was performed for conventional MSC markers. In the absence of EFs, as expected, MSCs were negative for the haematopoietic cell marker CD45 and displayed variable expression of the MSC-positive markers CD73, CD90 and CD105 (Fig. 7A) . Immediately after an EF of 200 mV/mm for 2 h, MSCs showed similar expression of the 4 markers compared with no EF control (Fig. 7A) , with no obvious differences observed when compared with untreated MSCs. Next, the osteogenesis assay was performed to evaluate the ability of MSCs to undergo osteogenic differentiation after experiencing an EF for 2 h. MSCs (donor 1, passages 3, 5, 7 and 10) were cultured either in the absence of EFs or in an EF of 200 mV/mm for 2 h. After that, cells were cultured in osteogenic medium for 4 weeks. Both in the absence and presence of EF, MSCs responded to osteogenic treatment in monolayers as assessed by Alizarin Red S staining for calcium (Fig. 7B) . Under the experimental conditions used, untreated cells did not show any calcium deposition with no EF or a DC EF of 200 mV/mm for 2 h (Fig. 7B ), while treatment with osteogenic medium resulted in calcium deposition (p < 0.05; t-test; Fig. 7B , C). Alizarin red staining and calcium deposition did not differ between EF-treated and untreated MSCs (p > 0.05; t-test; Fig. 7C ). Under treatment with osteogenic medium, either in the absence of EFs or in an EF of 200 mV/mm, the calcium deposition of cells at passage 10 was decreased compared with that of cells at passage 3 (p < 0.05; t-test; Fig. 7C ). These results confi rm the MSC nature of the cells 
Discussion
With the aims of understanding human bone marrow derived-MSC migration and developing a novel technique to facilitate a stem cell-based therapy in bone regeneration and repair, we analysed the migration of MSCs in the absence of directional stimuli and in the presence of a DC EF ranging from a low physiological level to higher than physiological levels. We report novel effects of applied EFs on adult human bone marrow-derived MSCs from multiple donors. We observed that: 1) MSCs migrated strongly directionally towards the anode, with even a small EF inducing signifi cant directional migration (<25 mV/mm), and that anodal-directed cell migration increased markedly Migration speeds every 2 h. Tt/T, trajectory speed; Td/T, displacement speed. Data are shown as mean ± SEM of three independent experiments. Anodally-directed migration was maintained for 10 h in culture. The rate of cell migration decreased with time in culture, both in control and EF-exposed cells.*, p < 0.05.
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as a function of increasing EF strength (up to 300 mV/ mm); 2) MSCs from all three donors tested responded to an applied EF with directional migration towards the anode; 3) the DC EF strengths did not cause any signifi cant damage to MSCs; 4) a DC EF of 200 mV/mm did not affect cell senescence; 5) cells were able to respond to an applied EF in prolonged culture; 6) a DC EF of 200 mV/mm did not affect the phenotype or the osteogenic potential of MSCs.
Migration of MSCs in EFs
Stem cell-based osteogenesis is of great clinical potential for patients suffering from bone injury, cancer and dysplasia. However, problems of homing stem cells to the target tissues and integrating stem cells within target sites still exist, which prevent or weaken the effect of therapy (De Bari et al., 2003; Fernandez-Tresguerres-HernandezGil et al., 2006; Fong et al., 2011) . Several biochemical 
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and biophysical methods to direct migration of stem cells have been explored to address these difficulties. The biochemical explorations include genetic manipulation of chemokines and their receptors such as CXCL12/CXCR-4 and stimulation of matrix metalloprotease, which enhances chemotaxis and migration of stem cells (Fong et al., 2011; Miller et al., 2008; . A magnetic fi eld as a biophysical method of cell guidance/homing has been shown to direct the migration of neural stem cells (Song et al., 2010) . We have investigated the role of EFs in directing the migration of MSCs, and provide evidence that physiological EFs robustly direct and speed MSC migration towards the anode. DC EFs are present naturally at wounds in a variety of different tissues and are a powerful directional guidance cue for epithelial cells, fi broblasts, vascular endothelial cells, keratinocytes, endothelial progenitor cells, and neurons McCaig et al., 2009; Robinson and Messerli, 2003; Trollinger et al., 2002; Yao et al., 2009; Zhao et al., 1996; Zhao et al., 2004; Zhao et al., 2006; Zhao et al., 2011) . Directed migration of cells in a DC EF is highly cell-type specifi c, since some cell types migrate cathodally and others anodally (Robinson, 1985) . Here, adult human bone marrow-derived MSCs showed strong anodal electrotaxis in physiological EFs, and this migration response increased with increasing EF strength between 25-300 mV/mm. Human induced pluripotent stem cell (hiPS) also show anodal electrotaxis in physiological EFs (Zhang et al., 2011) . However, mouse adipose-derived stromal cells (mASC) migrated towards the cathode in response to EFs (Hammerick et al., 2010) . In our lab, rat bone marrow-derived MSCs migrated towards the cathode in an EF of 200 mV/mm (unpublished data). There are two important differences in electrotaxis response between cells from human and those from rat or mouse. The fi rst difference is that human MSCs and hiPS migrated anodally, while mASCs and rat MSCs migrated in the opposite direction, cathodally, at similar EF strengths. Mature bone cells also show similar differences. Rat osteoblasts migrated towards the cathode (Ferrier et al., 1986; Ozkucur et al., 2009) . However, in our hands, human osteoblasts migrated anodally (data not shown). The second difference is that without an EF, human MSCs and hiPS migrated rapidly with a trajectory migration speed of ~25 μm/h (donor 1; passage 3) and ~16 μm/h; while mASCs migrated slowly at only ~0.7 μm/h. In an EF of 200 mV/mm, the migration speed of human MSCs and hiPS was increased to ~40 μm/h (donor 1; passage 3) and ~21 μm/h, respectively; while in a high EF strength of 600 mV/mm, mASC migration speed was increased only to ~3.5 μm/h. These differences in electrotaxis could be related to differences in cell types, tissue sources and species, thereby emphasising the need for comprehensive studies of the effects of EF application on a case-by-case basis. The underlying mechanisms of MSC electrotaxis for each cell type need to be clarifi ed.
It is especially interesting that human bone marrow MSCs showed signifi cant anodally-directed guidance even at a very low and physiological EF strength of ~25 mV/mm. We tested an even lower EF strength (10 mV/mm) at which cells did not show anodal-directed migration. Thus, we confi rmed that the threshold to induce directional migration of human bone marrow MSCs lies between 10 and 25 mV/ mm. There are many advantages to using low voltages for EF stimulation. The most important ones for developing a practical technique of EF application is that this will signifi cantly prevent electro-chemical product generation (from electrodes), the generation of heat, and effects on other cell types in 3D tissues Zhang et al., 2011) . This will also allow more prolonged application in clinical practice. In our study, an EF of 25 mV/mm is lower than the thresholds for the electrotaxis of endothelial progenitor cells and endothelial cells (Zhao et al., 2004; Zhao et al., 2011) . Thus, this would allow selective directed migration of MSCs whilst potentially avoiding effects on endothelial progenitor cells and endothelial cells.
Increasing the field strength increased the anodal directedness of MSCs and this directedness peaked at ~200-300 mV/mm. This fi eld strength range can be regarded as physiological, although slightly higher than the strength of endogenous wound EFs (~42-100 mV/mm) (Barker et al., 1982; Chiang et al., 1992) . Our fi ndings also indicate that application of either 200 mV/mm or 600 mV/mm for 2 h did not damage the cells. MSCs were able to respond to a DC EF for a prolonged duration of EF application. The cell phenotype and osteogenic potency were not altered by a DC EF. Our studies therefore indicate that adult human bone marrow-derived MSCs, which are attracting attention for tissue engineering and regenerative therapy, show robust directional migration and faster migration speed in a physiological DC EF. A very small EF (25 mV/mm) can be an effective cue to induce and guide migration of MSCs.
Migration and senescence of MSCs in vitro
The engineering of cell-based biological bone substitutes often requires large numbers of stem cells, thus raising a need for in vitro culture expansion. In this study, we expanded human bone marrow-derived MSCs of 3 donors and showed that the serially passaged MSCs exhibited progressive loss of migratory potential, either in the absence of directional cues or in the presence of a DC EF of 200 mV/mm. Alizarin Red S staining showed that MSCs at passage 10 exhibited a reduced osteogenic potential compared to earlier passages, either in an EF or in no EF. The SA-β-gal staining of MSCs showed more positive cells at passage 7 than at passage 3, either in the absence of directional cues or in the presence of an EF of 200 mV/mm. Our results also indicate that a DC EF does not damage the cells and does not affect cell senescence. Therefore, application of EFs does not cause cells to lose migratory potency, nor results in a low osteogenic potential; instead, cells becoming senescent could be one reason why they lose migratory potency, electrotaxis, and osteogenic potential. Recently, Siddappa et al. (2007) reported that serially passaged human MSCs showed low osteogenic potential and reduced proliferation potential with cells becoming senescent at late passage. Our fi ndings show that cell electrotaxis is passage-dependent with higher passages of MSCs showing lower directedness and migration rate, and this appears to be related to cell-intrinsic factors including cell senescence.
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Clinical relevance of EFs to bone regeneration and repair DC EFs exist in vivo and have profound infl uences on cell migration, orientation, and proliferation Nuccitelli, 2003; Zhao et al., 2006) . Disrupting the EFs impairs development and wound healing (Hotary and Robinson, 1992; McCaig et al., 2005) . Endogenous EFs take place at sites of bone fracture and therefore BMMSCs, commonly regarded as important players in bone regeneration, are likely to experience such EFs. Studies have shown the occurrence of: 1) electric potentials in stressed feline bone which generated a negative potential in the area of compression (Bassett and Becker, 1962) , and 2) inward endogenous ionic current densities in damaged mouse bone, which ranged from ~5 to 129 μA/ cm 2 (Borgens, 1984) . Based on existing data, a model supports that the wound site of bone would be the anode of the endogenous EFs . Our fi ndings of MSC migration towards the anode would be in keeping with this model. However, whether those endogenous EFs have any effect on migration of MSCs in vivo is yet to be determined.
In orthopaedics, the clinical application of EFs in fracture healing and spinal fusion has been reported (Brighton et al., 1981; Brighton and Pollack, 1985; Dejardin et al., 2001; Gan and Glazer, 2006; Hodges et al., 2003; Lavine and Grodzinsky, 1987; . For the application of DC EFs, the amount of current applied that produces osteogenesis is between 5 and 20 μA (Brighton et al., 1981; Hodges et al., 2003; . The relationship between current and the electrical fi eld is governed by Ohm's law: E = J.ρ, where E is the EF (V/cm), J is the current density (in A/cm 2 ), and ρ is the resistivity (Ωcm) (see McCaig et al., 2005) . The resistivity of rabbit femurs is ~ 8 to 500 KΩcm (Liboff et al., 1975; Singh and Saha, 1984) . Thus, assuming that this range of resistivities is representative of the human tissue, the voltage of clinically applied EFs across the injury is ~16 to 1,000 mV/mm; similarly, the endogenous wound current in mouse bone would generate an EF between 4 to 6,450 mV/mm. Therefore, the threshold of EF strength effective in this study (25 mV/mm) is at the low end of both endogenous wound-induced EFs and of clinically applied EFs.
It has to be noted that, clinically, for fracture healing or spinal fusion the cathode is usually placed in the injury site while the anode is placed in the soft tissue away from the injury (Brighton et al., 1981; Brighton and Pollack, 1985; Dejardin et al., 2001; Gan and Glazer, 2006; Hodges et al., 2003; Lavine and Grodzinsky, 1987; . A recent study that attempted to identify the mode of action of DC EF treatment with the cathode implanted at the wound site reported up-regulated gene expression of the osteoinductive bone morphogenetic proteins BMP-2, -6, and -7 (Fredericks et al., 2007) . While EF application seems to promote bone formation and repair, so far no study has addressed the effects of EF application on cell migration in vivo. Although our in vitro fi ndings cannot be extrapolated to an in vivo setting, it is tempting to speculate that a customised biphasic EF treatment at the bone repair site that switches polarity from a brief initial anodal attraction of MSCs to a sustained cathodal bone stimulation could result in enhanced and a more effective repair outcome. In addition, DC EFs may be utilised to standardise bone tissue engineering approaches via spatial and temporal controls of cell migration into 3D scaffolds to generate bone substitutes. Thus, our fi ndings provide a new perspective for the clinical application of DC EFs in human bone regeneration and repair.
In conclusion, small physiological DC EFs almost doubled the migration rate and induced robust directional migration of human bone marrow-derived MSCs towards the anode (positive electrode). This is a primary response of the MSCs and did not require any other cell type. Human bone marrow MSCs are of great potential in tissue engineering and regenerative therapy, and our data indicate that applied EFs of a similar and a greater magnitude to naturally occurring (wound-induced) EFs could be used to control homing of human bone marrow-derived MSCs to wounds in general and to injury sites in bone. Our fi ndings encourage the development of a technique for application of EFs in vivo to guide migration of bone marrow MSCs in bone regeneration and healing therapy.
Discussion with Reviewers
Reviewer I: How do the authors envision the application of their fi ndings clinically, as applied EFs are already being used for bone fracture healing and for spinal fusion? Authors: Our in vitro proof-of-concept study provides evidence that MSCs migrate in response to EFs. At present, it would be premature to place our fi ndings into a clinical perspective but it is tempting to speculate a twofold application: 1) to direct and enhance migration of endogenous bone marrow MSCs to the site of fracture in vivo; 2) to standardise bone tissue engineering approaches via spatial and temporal controls of MSC migration into 3D scaffolds for the generation of bone substitutes.
Reviewer I: The current fi ndings of anodal migration of cells are not consistent with cathodal healing of bone that is observed clinically (albeit the time frames of the two are very different). Authors: Our fi ndings may be in apparent discrepancy with the current application of EFs in vivo with the placement Z Zhao et al.
Electrotaxis of bone marrow mesenchymal stem cells of the cathode at the site of healing. However, while prolonged cathodal stimulation seems to promote bone formation, possibly as a result of EF-induced up-regulation of osteoinductive BMPs at the wound site, as described by Fredericks et al. (2007) , so far no study has addressed the effects of EF application on cell migration in vivo, which is likely to be an early response. Although our in vitro fi ndings cannot be extrapolated to an in vivo setting, it is possible that a biphasic EF treatment at the bone repair site that switches polarity from a brief initial anodal attraction of MSCs to a sustained cathodal bone stimulation could result in a more effective repair outcome.
Reviewer II: At the rate of cell migration detected, which is about 29 mm/month, how do the authors think these results might be applied clinically? Authors: The migration speed observed in our in vitro study may not appear clinically relevant. However, the in vivo scenario is far more complex, with speed of migration being affected by several other factors, such as gradients of chemokines and other signalling molecules, receptors expressed on MSCs, interactions with various cell types and surrounding extracellular matrix. In vivo studies will be necessary to investigate the effects and mechanisms of EF application on MSC migration during bone regeneration and repair.
